cardonilizumab
Showing 1 - 1 of 1
Biliary Tract Cancer, Candonilimab, Claudin 18.2 Trial in Shanghai (cardonilizumab, LM-302)
Recruiting
- Biliary Tract Cancer
- +2 more
- cardonilizumab
- LM-302
-
Shanghai, ChinaZhongshan hospital, Fudan University
Aug 12, 2023